Drug Allergy Labels After Drug Allergy Investigation

Status Completed

Clinical Trial Summary

The aim of this study is to investigate the degree of match between the drug allergy label in the hospital's electronic health record and primary care's electronic health record among patients who previously have been drug allergy tested.

Clinical Trial Description

Patients who previously have been penicillin allergy tested in 2017 to 2019 at the Allergy Clinic at Gentofte Hospital is included in the study. Patients are identified through a drug allergy database at the department. A letter describing the study and the data collection process will be sent to the patients' General Practice offices (GP). Data collection: The patients GP's are contacted by telephone where the information about the drug allergy labels in their electronical medical charts are shared. On the same day as the phone contact to the GP's office, the patient's electronical health record in the hospital system is accessed in order to gain information about the current drug allergy registrations. Predictors for the explanatory analysis is collected partly through the phone call to the GP (such as numbers of patients and physicians at each GP and the electronic health system used), from the hospital electronic health record (such as number of hospital admissions since drug allergy testing) and from the drug allergy database. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04827602
Study type	Observational
Source	University Hospital, Gentofte, Copenhagen
Contact
Status	Completed
Phase
Start date	April 15, 2021
Completion date	July 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02839551` - Optimal Doses for Drug Provocation Tests to Beta-lactams	N/A
Completed	`NCT00198419` - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)	Phase 1
Completed	`NCT02839811` - Medical Device for Drug Allergy Diagnosis	N/A
Completed	`NCT02983630` - Allergy Testing of Patients Labeled as Penicillin Allergic	N/A
Completed	`NCT00198458` - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)	Phase 1
Recruiting	`NCT04330118` - Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Completed	`NCT04421638` - Cephalosporin Hypersensitivity
Recruiting	`NCT02031120` - Management of Drug Hypersensitivity in Children	N/A
Completed	`NCT01276314` - Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions	N/A
Terminated	`NCT00505648` - Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)	Phase 3
Completed	`NCT03158831` - Drug Challenges Without Prior Skin Testing	Phase 1
Completed	`NCT03076749` - Predictive Models for Betalactam Allergy	N/A
Active, not recruiting	`NCT06428162` - a Cross-sectional Study of Pharmacovigilance Practices Adherence Between Healthcare Providers in North African Nation
Terminated	`NCT02844712` - Negative Predictive Value of Drug Provocation Tests to Beta-lactams	N/A
Completed	`NCT03743220` - Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)
Completed	`NCT03771118` - Drug Provocation Test (DPT) to Paracetamol
Not yet recruiting	`NCT06406114` - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing	Phase 2
Completed	`NCT05269082` - A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults